Acadia Healthcare Company, Inc. $ACHC Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 19.2% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 222,444 shares of the company’s stock after selling 52,869 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Acadia Healthcare were worth $6,569,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. EverSource Wealth Advisors LLC grew its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the period. Wells Fargo & Company MN raised its position in Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the period. Allworth Financial LP acquired a new stake in shares of Acadia Healthcare in the second quarter valued at about $45,000. Global Retirement Partners LLC acquired a new position in Acadia Healthcare during the 2nd quarter worth approximately $68,000. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Acadia Healthcare by 4,264.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after acquiring an additional 5,203 shares during the period.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their target price for the company from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Cantor Fitzgerald restated a “neutral” rating on shares of Acadia Healthcare in a research note on Wednesday, July 29th. KeyCorp lifted their target price on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. UBS Group increased their price target on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Finally, Barclays upped their target price on Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $29.85.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $27.50 on Wednesday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The firm’s 50-day simple moving average is $30.67 and its 200-day simple moving average is $26.74. The firm has a market cap of $2.56 billion, a PE ratio of -2.21, a price-to-earnings-growth ratio of 9.06 and a beta of 0.62.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same period in the previous year, the company earned $0.83 earnings per share. Acadia Healthcare’s quarterly revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities analysts forecast that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.